nodes	percent_of_prediction	percent_of_DWPC	metapath
Triamcinolone—CYP3A4—bone cancer	0.349	0.505	CbGaD
Triamcinolone—PTGS2—bone cancer	0.342	0.495	CbGaD
Triamcinolone—BCHE—Cisplatin—bone cancer	0.0997	0.534	CbGbCtD
Triamcinolone—PTGS2—Cisplatin—bone cancer	0.0767	0.411	CbGbCtD
Triamcinolone—CYP3A4—Doxorubicin—bone cancer	0.0102	0.0545	CbGbCtD
Triamcinolone—Fluocinonide—SMO—bone cancer	0.00232	0.433	CrCbGaD
Triamcinolone—Blister—Doxorubicin—bone cancer	0.000488	0.00418	CcSEcCtD
Triamcinolone—Abscess—Epirubicin—bone cancer	0.00048	0.00411	CcSEcCtD
Triamcinolone—Dermatitis atopic—Doxorubicin—bone cancer	0.000475	0.00407	CcSEcCtD
Triamcinolone—Neuritis—Doxorubicin—bone cancer	0.000471	0.00403	CcSEcCtD
Triamcinolone—Glycosuria—Epirubicin—bone cancer	0.000469	0.00402	CcSEcCtD
Triamcinolone—Stinging—Epirubicin—bone cancer	0.000469	0.00402	CcSEcCtD
Triamcinolone—Petechiae—Epirubicin—bone cancer	0.000462	0.00396	CcSEcCtD
Triamcinolone—Pancreatitis—Cisplatin—bone cancer	0.000455	0.0039	CcSEcCtD
Triamcinolone—Sweating increased—Cisplatin—bone cancer	0.000452	0.00387	CcSEcCtD
Triamcinolone—Abscess—Doxorubicin—bone cancer	0.000444	0.00381	CcSEcCtD
Triamcinolone—Stinging—Doxorubicin—bone cancer	0.000434	0.00372	CcSEcCtD
Triamcinolone—Glycosuria—Doxorubicin—bone cancer	0.000434	0.00372	CcSEcCtD
Triamcinolone—Ulcer—Methotrexate—bone cancer	0.000429	0.00368	CcSEcCtD
Triamcinolone—Petechiae—Doxorubicin—bone cancer	0.000427	0.00366	CcSEcCtD
Triamcinolone—Arthropathy—Epirubicin—bone cancer	0.000418	0.00358	CcSEcCtD
Triamcinolone—Vasculitis—Methotrexate—bone cancer	0.000416	0.00356	CcSEcCtD
Triamcinolone—Cough increased—Epirubicin—bone cancer	0.000415	0.00355	CcSEcCtD
Triamcinolone—Acute coronary syndrome—Cisplatin—bone cancer	0.000408	0.00349	CcSEcCtD
Triamcinolone—Myocardial infarction—Cisplatin—bone cancer	0.000406	0.00347	CcSEcCtD
Triamcinolone—Neuropathy peripheral—Cisplatin—bone cancer	0.000406	0.00347	CcSEcCtD
Triamcinolone—Conjunctivitis—Cisplatin—bone cancer	0.000402	0.00345	CcSEcCtD
Triamcinolone—Ulcer—Epirubicin—bone cancer	0.000402	0.00344	CcSEcCtD
Triamcinolone—Skin exfoliation—Methotrexate—bone cancer	0.000388	0.00332	CcSEcCtD
Triamcinolone—Arthropathy—Doxorubicin—bone cancer	0.000387	0.00331	CcSEcCtD
Triamcinolone—Cough increased—Doxorubicin—bone cancer	0.000384	0.00329	CcSEcCtD
Triamcinolone—Hiccups—Epirubicin—bone cancer	0.00038	0.00325	CcSEcCtD
Triamcinolone—Bradycardia—Cisplatin—bone cancer	0.000378	0.00324	CcSEcCtD
Triamcinolone—Dermatitis contact—Epirubicin—bone cancer	0.000375	0.00322	CcSEcCtD
Triamcinolone—Ulcer—Doxorubicin—bone cancer	0.000372	0.00318	CcSEcCtD
Triamcinolone—Ecchymosis—Methotrexate—bone cancer	0.000367	0.00314	CcSEcCtD
Triamcinolone—Skin exfoliation—Epirubicin—bone cancer	0.000363	0.00311	CcSEcCtD
Triamcinolone—Candida infection—Epirubicin—bone cancer	0.000363	0.00311	CcSEcCtD
Triamcinolone—Pulmonary oedema—Methotrexate—bone cancer	0.000361	0.00309	CcSEcCtD
Triamcinolone—Fluid retention—Epirubicin—bone cancer	0.000361	0.00309	CcSEcCtD
Triamcinolone—Neuropathy—Epirubicin—bone cancer	0.000357	0.00306	CcSEcCtD
Triamcinolone—Hiccups—Doxorubicin—bone cancer	0.000352	0.00301	CcSEcCtD
Triamcinolone—Dermatitis contact—Doxorubicin—bone cancer	0.000347	0.00298	CcSEcCtD
Triamcinolone—Ecchymosis—Epirubicin—bone cancer	0.000343	0.00294	CcSEcCtD
Triamcinolone—Thrombophlebitis—Methotrexate—bone cancer	0.00034	0.00292	CcSEcCtD
Triamcinolone—Diabetes mellitus—Methotrexate—bone cancer	0.000339	0.0029	CcSEcCtD
Triamcinolone—Pulmonary oedema—Epirubicin—bone cancer	0.000338	0.0029	CcSEcCtD
Triamcinolone—Skin exfoliation—Doxorubicin—bone cancer	0.000336	0.00287	CcSEcCtD
Triamcinolone—Candida infection—Doxorubicin—bone cancer	0.000336	0.00287	CcSEcCtD
Triamcinolone—Fluid retention—Doxorubicin—bone cancer	0.000334	0.00286	CcSEcCtD
Triamcinolone—Arrhythmia—Cisplatin—bone cancer	0.000332	0.00284	CcSEcCtD
Triamcinolone—Neuropathy—Doxorubicin—bone cancer	0.00033	0.00283	CcSEcCtD
Triamcinolone—Erythema—Cisplatin—bone cancer	0.000323	0.00277	CcSEcCtD
Triamcinolone—Thrombophlebitis—Epirubicin—bone cancer	0.000319	0.00273	CcSEcCtD
Triamcinolone—Ecchymosis—Doxorubicin—bone cancer	0.000318	0.00272	CcSEcCtD
Triamcinolone—Diabetes mellitus—Epirubicin—bone cancer	0.000317	0.00272	CcSEcCtD
Triamcinolone—Pulmonary oedema—Doxorubicin—bone cancer	0.000313	0.00268	CcSEcCtD
Triamcinolone—Vascular purpura—Epirubicin—bone cancer	0.000308	0.00264	CcSEcCtD
Triamcinolone—Budesonide—CYP3A4—bone cancer	0.000305	0.057	CrCbGaD
Triamcinolone—Anaphylactoid reaction—Methotrexate—bone cancer	0.000304	0.00261	CcSEcCtD
Triamcinolone—Cardiac failure congestive—Epirubicin—bone cancer	0.000304	0.0026	CcSEcCtD
Triamcinolone—Ill-defined disorder—Cisplatin—bone cancer	0.0003	0.00257	CcSEcCtD
Triamcinolone—Fluticasone furoate—CYP3A4—bone cancer	0.000299	0.0559	CrCbGaD
Triamcinolone—Thrombophlebitis—Doxorubicin—bone cancer	0.000295	0.00252	CcSEcCtD
Triamcinolone—Osteoarthritis—Methotrexate—bone cancer	0.000295	0.00252	CcSEcCtD
Triamcinolone—Increased appetite—Epirubicin—bone cancer	0.000294	0.00251	CcSEcCtD
Triamcinolone—Diabetes mellitus—Doxorubicin—bone cancer	0.000293	0.00251	CcSEcCtD
Triamcinolone—Malaise—Cisplatin—bone cancer	0.000292	0.0025	CcSEcCtD
Triamcinolone—Dermatitis bullous—Epirubicin—bone cancer	0.000289	0.00247	CcSEcCtD
Triamcinolone—Purpura—Epirubicin—bone cancer	0.000286	0.00245	CcSEcCtD
Triamcinolone—Vascular purpura—Doxorubicin—bone cancer	0.000285	0.00244	CcSEcCtD
Triamcinolone—Anaphylactoid reaction—Epirubicin—bone cancer	0.000285	0.00244	CcSEcCtD
Triamcinolone—Cardiac failure congestive—Doxorubicin—bone cancer	0.000281	0.00241	CcSEcCtD
Triamcinolone—Convulsion—Cisplatin—bone cancer	0.00028	0.0024	CcSEcCtD
Triamcinolone—Mood swings—Methotrexate—bone cancer	0.000279	0.00239	CcSEcCtD
Triamcinolone—Osteoarthritis—Epirubicin—bone cancer	0.000276	0.00236	CcSEcCtD
Triamcinolone—Myalgia—Cisplatin—bone cancer	0.000275	0.00236	CcSEcCtD
Triamcinolone—Discomfort—Cisplatin—bone cancer	0.000272	0.00233	CcSEcCtD
Triamcinolone—Increased appetite—Doxorubicin—bone cancer	0.000272	0.00233	CcSEcCtD
Triamcinolone—Affect lability—Epirubicin—bone cancer	0.000271	0.00232	CcSEcCtD
Triamcinolone—Dermatitis bullous—Doxorubicin—bone cancer	0.000267	0.00229	CcSEcCtD
Triamcinolone—Purpura—Doxorubicin—bone cancer	0.000265	0.00227	CcSEcCtD
Triamcinolone—Oedema—Cisplatin—bone cancer	0.000264	0.00226	CcSEcCtD
Triamcinolone—Anaphylactic shock—Cisplatin—bone cancer	0.000264	0.00226	CcSEcCtD
Triamcinolone—Anaphylactoid reaction—Doxorubicin—bone cancer	0.000264	0.00226	CcSEcCtD
Triamcinolone—Alclometasone—CYP3A4—bone cancer	0.000263	0.0491	CrCbGaD
Triamcinolone—Cardiac arrest—Epirubicin—bone cancer	0.000262	0.00225	CcSEcCtD
Triamcinolone—Infection—Cisplatin—bone cancer	0.000262	0.00225	CcSEcCtD
Triamcinolone—Mood swings—Epirubicin—bone cancer	0.000261	0.00224	CcSEcCtD
Triamcinolone—Tachycardia—Cisplatin—bone cancer	0.000258	0.00221	CcSEcCtD
Triamcinolone—Flunisolide—CYP3A4—bone cancer	0.000256	0.0478	CrCbGaD
Triamcinolone—Osteoarthritis—Doxorubicin—bone cancer	0.000255	0.00219	CcSEcCtD
Triamcinolone—Hyperhidrosis—Cisplatin—bone cancer	0.000255	0.00219	CcSEcCtD
Triamcinolone—Asthma—Methotrexate—bone cancer	0.000255	0.00218	CcSEcCtD
Triamcinolone—Paramethasone—CYP3A4—bone cancer	0.000252	0.0472	CrCbGaD
Triamcinolone—Affect lability—Doxorubicin—bone cancer	0.000251	0.00215	CcSEcCtD
Triamcinolone—Pancreatitis—Methotrexate—bone cancer	0.00025	0.00214	CcSEcCtD
Triamcinolone—Fluorometholone—CYP3A4—bone cancer	0.000246	0.0461	CrCbGaD
Triamcinolone—Muscular weakness—Epirubicin—bone cancer	0.000243	0.00208	CcSEcCtD
Triamcinolone—Cardiac arrest—Doxorubicin—bone cancer	0.000243	0.00208	CcSEcCtD
Triamcinolone—Mood swings—Doxorubicin—bone cancer	0.000242	0.00207	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Cisplatin—bone cancer	0.00024	0.00206	CcSEcCtD
Triamcinolone—Abdominal distension—Epirubicin—bone cancer	0.00024	0.00206	CcSEcCtD
Triamcinolone—Asthma—Epirubicin—bone cancer	0.000238	0.00204	CcSEcCtD
Triamcinolone—Influenza—Epirubicin—bone cancer	0.000238	0.00204	CcSEcCtD
Triamcinolone—Methylprednisolone—CYP3A4—bone cancer	0.000238	0.0445	CrCbGaD
Triamcinolone—Paraesthesia—Cisplatin—bone cancer	0.000237	0.00203	CcSEcCtD
Triamcinolone—Upper respiratory tract infection—Methotrexate—bone cancer	0.000237	0.00203	CcSEcCtD
Triamcinolone—Dyspnoea—Cisplatin—bone cancer	0.000235	0.00202	CcSEcCtD
Triamcinolone—Pancreatitis—Epirubicin—bone cancer	0.000234	0.002	CcSEcCtD
Triamcinolone—Bronchitis—Epirubicin—bone cancer	0.000229	0.00196	CcSEcCtD
Triamcinolone—Pain—Cisplatin—bone cancer	0.000226	0.00193	CcSEcCtD
Triamcinolone—Muscular weakness—Doxorubicin—bone cancer	0.000225	0.00193	CcSEcCtD
Triamcinolone—Abdominal distension—Doxorubicin—bone cancer	0.000222	0.0019	CcSEcCtD
Triamcinolone—Upper respiratory tract infection—Epirubicin—bone cancer	0.000222	0.0019	CcSEcCtD
Triamcinolone—Conjunctivitis—Methotrexate—bone cancer	0.000221	0.00189	CcSEcCtD
Triamcinolone—Influenza—Doxorubicin—bone cancer	0.000221	0.00189	CcSEcCtD
Triamcinolone—Asthma—Doxorubicin—bone cancer	0.000221	0.00189	CcSEcCtD
Triamcinolone—Feeling abnormal—Cisplatin—bone cancer	0.000218	0.00186	CcSEcCtD
Triamcinolone—Weight increased—Epirubicin—bone cancer	0.000217	0.00186	CcSEcCtD
Triamcinolone—Pancreatitis—Doxorubicin—bone cancer	0.000216	0.00185	CcSEcCtD
Triamcinolone—Epistaxis—Methotrexate—bone cancer	0.000214	0.00183	CcSEcCtD
Triamcinolone—Bronchitis—Doxorubicin—bone cancer	0.000212	0.00182	CcSEcCtD
Triamcinolone—Body temperature increased—Cisplatin—bone cancer	0.000209	0.00179	CcSEcCtD
Triamcinolone—Neuropathy peripheral—Epirubicin—bone cancer	0.000208	0.00178	CcSEcCtD
Triamcinolone—Conjunctivitis—Epirubicin—bone cancer	0.000207	0.00177	CcSEcCtD
Triamcinolone—Upper respiratory tract infection—Doxorubicin—bone cancer	0.000205	0.00176	CcSEcCtD
Triamcinolone—Haemoglobin—Methotrexate—bone cancer	0.000205	0.00175	CcSEcCtD
Triamcinolone—Haemorrhage—Methotrexate—bone cancer	0.000204	0.00175	CcSEcCtD
Triamcinolone—Pharyngitis—Methotrexate—bone cancer	0.000202	0.00173	CcSEcCtD
Triamcinolone—Weight increased—Doxorubicin—bone cancer	0.000201	0.00172	CcSEcCtD
Triamcinolone—Epistaxis—Epirubicin—bone cancer	0.0002	0.00172	CcSEcCtD
Triamcinolone—Hypersensitivity—Cisplatin—bone cancer	0.000194	0.00167	CcSEcCtD
Triamcinolone—Bradycardia—Epirubicin—bone cancer	0.000194	0.00166	CcSEcCtD
Triamcinolone—Neuropathy peripheral—Doxorubicin—bone cancer	0.000193	0.00165	CcSEcCtD
Triamcinolone—Haemoglobin—Epirubicin—bone cancer	0.000192	0.00164	CcSEcCtD
Triamcinolone—Rhinitis—Epirubicin—bone cancer	0.000191	0.00164	CcSEcCtD
Triamcinolone—Conjunctivitis—Doxorubicin—bone cancer	0.000191	0.00164	CcSEcCtD
Triamcinolone—Haemorrhage—Epirubicin—bone cancer	0.000191	0.00163	CcSEcCtD
Triamcinolone—Asthenia—Cisplatin—bone cancer	0.000189	0.00162	CcSEcCtD
Triamcinolone—Pharyngitis—Epirubicin—bone cancer	0.000189	0.00162	CcSEcCtD
Triamcinolone—Epistaxis—Doxorubicin—bone cancer	0.000185	0.00159	CcSEcCtD
Triamcinolone—Prednisone—CYP3A4—bone cancer	0.000182	0.0341	CrCbGaD
Triamcinolone—Bradycardia—Doxorubicin—bone cancer	0.00018	0.00154	CcSEcCtD
Triamcinolone—Fluticasone Propionate—CYP3A4—bone cancer	0.00018	0.0336	CrCbGaD
Triamcinolone—Erythema—Methotrexate—bone cancer	0.000177	0.00152	CcSEcCtD
Triamcinolone—Haemoglobin—Doxorubicin—bone cancer	0.000177	0.00152	CcSEcCtD
Triamcinolone—Rhinitis—Doxorubicin—bone cancer	0.000177	0.00152	CcSEcCtD
Triamcinolone—Haemorrhage—Doxorubicin—bone cancer	0.000177	0.00151	CcSEcCtD
Triamcinolone—Pharyngitis—Doxorubicin—bone cancer	0.000175	0.0015	CcSEcCtD
Triamcinolone—Dysgeusia—Methotrexate—bone cancer	0.000174	0.00149	CcSEcCtD
Triamcinolone—Back pain—Methotrexate—bone cancer	0.000172	0.00147	CcSEcCtD
Triamcinolone—Arrhythmia—Epirubicin—bone cancer	0.00017	0.00146	CcSEcCtD
Triamcinolone—Prednisolone—CYP3A4—bone cancer	0.000168	0.0314	CrCbGaD
Triamcinolone—Vomiting—Cisplatin—bone cancer	0.000168	0.00144	CcSEcCtD
Triamcinolone—Rash—Cisplatin—bone cancer	0.000166	0.00143	CcSEcCtD
Triamcinolone—Dermatitis—Cisplatin—bone cancer	0.000166	0.00142	CcSEcCtD
Triamcinolone—Erythema—Epirubicin—bone cancer	0.000166	0.00142	CcSEcCtD
Triamcinolone—Ill-defined disorder—Methotrexate—bone cancer	0.000165	0.00141	CcSEcCtD
Triamcinolone—Betamethasone—CYP3A4—bone cancer	0.000164	0.0308	CrCbGaD
Triamcinolone—Dysgeusia—Epirubicin—bone cancer	0.000163	0.00139	CcSEcCtD
Triamcinolone—Betamethasone—PTGS2—bone cancer	0.000161	0.0301	CrCbGaD
Triamcinolone—Back pain—Epirubicin—bone cancer	0.000161	0.00138	CcSEcCtD
Triamcinolone—Malaise—Methotrexate—bone cancer	0.00016	0.00137	CcSEcCtD
Triamcinolone—Vertigo—Methotrexate—bone cancer	0.000159	0.00137	CcSEcCtD
Triamcinolone—Arrhythmia—Doxorubicin—bone cancer	0.000158	0.00135	CcSEcCtD
Triamcinolone—Nausea—Cisplatin—bone cancer	0.000157	0.00134	CcSEcCtD
Triamcinolone—Cough—Methotrexate—bone cancer	0.000155	0.00133	CcSEcCtD
Triamcinolone—Ill-defined disorder—Epirubicin—bone cancer	0.000154	0.00132	CcSEcCtD
Triamcinolone—Convulsion—Methotrexate—bone cancer	0.000154	0.00132	CcSEcCtD
Triamcinolone—Erythema—Doxorubicin—bone cancer	0.000154	0.00132	CcSEcCtD
Triamcinolone—Myalgia—Methotrexate—bone cancer	0.000151	0.00129	CcSEcCtD
Triamcinolone—Dysgeusia—Doxorubicin—bone cancer	0.00015	0.00129	CcSEcCtD
Triamcinolone—Malaise—Epirubicin—bone cancer	0.00015	0.00128	CcSEcCtD
Triamcinolone—Discomfort—Methotrexate—bone cancer	0.000149	0.00128	CcSEcCtD
Triamcinolone—Vertigo—Epirubicin—bone cancer	0.000149	0.00128	CcSEcCtD
Triamcinolone—Syncope—Epirubicin—bone cancer	0.000149	0.00128	CcSEcCtD
Triamcinolone—Back pain—Doxorubicin—bone cancer	0.000149	0.00127	CcSEcCtD
Triamcinolone—Loss of consciousness—Epirubicin—bone cancer	0.000146	0.00125	CcSEcCtD
Triamcinolone—Cough—Epirubicin—bone cancer	0.000145	0.00124	CcSEcCtD
Triamcinolone—Anaphylactic shock—Methotrexate—bone cancer	0.000145	0.00124	CcSEcCtD
Triamcinolone—Convulsion—Epirubicin—bone cancer	0.000144	0.00123	CcSEcCtD
Triamcinolone—Infection—Methotrexate—bone cancer	0.000144	0.00123	CcSEcCtD
Triamcinolone—Hypertension—Epirubicin—bone cancer	0.000143	0.00123	CcSEcCtD
Triamcinolone—Ill-defined disorder—Doxorubicin—bone cancer	0.000143	0.00122	CcSEcCtD
Triamcinolone—Myalgia—Epirubicin—bone cancer	0.000141	0.00121	CcSEcCtD
Triamcinolone—Hyperhidrosis—Methotrexate—bone cancer	0.00014	0.0012	CcSEcCtD
Triamcinolone—Discomfort—Epirubicin—bone cancer	0.00014	0.0012	CcSEcCtD
Triamcinolone—Malaise—Doxorubicin—bone cancer	0.000139	0.00119	CcSEcCtD
Triamcinolone—Dry mouth—Epirubicin—bone cancer	0.000138	0.00118	CcSEcCtD
Triamcinolone—Vertigo—Doxorubicin—bone cancer	0.000138	0.00118	CcSEcCtD
Triamcinolone—Syncope—Doxorubicin—bone cancer	0.000138	0.00118	CcSEcCtD
Triamcinolone—Oedema—Epirubicin—bone cancer	0.000136	0.00116	CcSEcCtD
Triamcinolone—Anaphylactic shock—Epirubicin—bone cancer	0.000136	0.00116	CcSEcCtD
Triamcinolone—Loss of consciousness—Doxorubicin—bone cancer	0.000135	0.00116	CcSEcCtD
Triamcinolone—Infection—Epirubicin—bone cancer	0.000135	0.00115	CcSEcCtD
Triamcinolone—Cough—Doxorubicin—bone cancer	0.000134	0.00115	CcSEcCtD
Triamcinolone—Shock—Epirubicin—bone cancer	0.000133	0.00114	CcSEcCtD
Triamcinolone—Convulsion—Doxorubicin—bone cancer	0.000133	0.00114	CcSEcCtD
Triamcinolone—Hypertension—Doxorubicin—bone cancer	0.000133	0.00114	CcSEcCtD
Triamcinolone—Tachycardia—Epirubicin—bone cancer	0.000132	0.00113	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000132	0.00113	CcSEcCtD
Triamcinolone—Hyperhidrosis—Epirubicin—bone cancer	0.000131	0.00112	CcSEcCtD
Triamcinolone—Insomnia—Methotrexate—bone cancer	0.000131	0.00112	CcSEcCtD
Triamcinolone—Myalgia—Doxorubicin—bone cancer	0.000131	0.00112	CcSEcCtD
Triamcinolone—Paraesthesia—Methotrexate—bone cancer	0.00013	0.00111	CcSEcCtD
Triamcinolone—Discomfort—Doxorubicin—bone cancer	0.000129	0.00111	CcSEcCtD
Triamcinolone—Dyspnoea—Methotrexate—bone cancer	0.000129	0.00111	CcSEcCtD
Triamcinolone—Hydrocortisone—CYP3A4—bone cancer	0.000128	0.024	CrCbGaD
Triamcinolone—Dry mouth—Doxorubicin—bone cancer	0.000128	0.0011	CcSEcCtD
Triamcinolone—Dyspepsia—Methotrexate—bone cancer	0.000127	0.00109	CcSEcCtD
Triamcinolone—Anaphylactic shock—Doxorubicin—bone cancer	0.000125	0.00107	CcSEcCtD
Triamcinolone—Oedema—Doxorubicin—bone cancer	0.000125	0.00107	CcSEcCtD
Triamcinolone—Fatigue—Methotrexate—bone cancer	0.000125	0.00107	CcSEcCtD
Triamcinolone—Infection—Doxorubicin—bone cancer	0.000125	0.00107	CcSEcCtD
Triamcinolone—Pain—Methotrexate—bone cancer	0.000124	0.00106	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000123	0.00106	CcSEcCtD
Triamcinolone—Shock—Doxorubicin—bone cancer	0.000123	0.00106	CcSEcCtD
Triamcinolone—Insomnia—Epirubicin—bone cancer	0.000123	0.00105	CcSEcCtD
Triamcinolone—Tachycardia—Doxorubicin—bone cancer	0.000122	0.00105	CcSEcCtD
Triamcinolone—Paraesthesia—Epirubicin—bone cancer	0.000122	0.00104	CcSEcCtD
Triamcinolone—Hyperhidrosis—Doxorubicin—bone cancer	0.000121	0.00104	CcSEcCtD
Triamcinolone—Dyspnoea—Epirubicin—bone cancer	0.000121	0.00104	CcSEcCtD
Triamcinolone—Feeling abnormal—Methotrexate—bone cancer	0.000119	0.00102	CcSEcCtD
Triamcinolone—Dyspepsia—Epirubicin—bone cancer	0.000119	0.00102	CcSEcCtD
Triamcinolone—Fatigue—Epirubicin—bone cancer	0.000117	0.001	CcSEcCtD
Triamcinolone—Pain—Epirubicin—bone cancer	0.000116	0.000993	CcSEcCtD
Triamcinolone—Urticaria—Methotrexate—bone cancer	0.000115	0.000986	CcSEcCtD
Triamcinolone—Body temperature increased—Methotrexate—bone cancer	0.000114	0.000981	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000114	0.000979	CcSEcCtD
Triamcinolone—Insomnia—Doxorubicin—bone cancer	0.000113	0.000972	CcSEcCtD
Triamcinolone—Paraesthesia—Doxorubicin—bone cancer	0.000113	0.000965	CcSEcCtD
Triamcinolone—Dyspnoea—Doxorubicin—bone cancer	0.000112	0.000958	CcSEcCtD
Triamcinolone—Feeling abnormal—Epirubicin—bone cancer	0.000112	0.000957	CcSEcCtD
Triamcinolone—Dyspepsia—Doxorubicin—bone cancer	0.00011	0.000946	CcSEcCtD
Triamcinolone—Fatigue—Doxorubicin—bone cancer	0.000108	0.000926	CcSEcCtD
Triamcinolone—Urticaria—Epirubicin—bone cancer	0.000108	0.000922	CcSEcCtD
Triamcinolone—Pain—Doxorubicin—bone cancer	0.000107	0.000919	CcSEcCtD
Triamcinolone—Body temperature increased—Epirubicin—bone cancer	0.000107	0.000918	CcSEcCtD
Triamcinolone—Hypersensitivity—Methotrexate—bone cancer	0.000107	0.000914	CcSEcCtD
Triamcinolone—Asthenia—Methotrexate—bone cancer	0.000104	0.00089	CcSEcCtD
Triamcinolone—Feeling abnormal—Doxorubicin—bone cancer	0.000103	0.000885	CcSEcCtD
Triamcinolone—Pruritus—Methotrexate—bone cancer	0.000102	0.000878	CcSEcCtD
Triamcinolone—Hypersensitivity—Epirubicin—bone cancer	9.99e-05	0.000855	CcSEcCtD
Triamcinolone—Urticaria—Doxorubicin—bone cancer	9.96e-05	0.000853	CcSEcCtD
Triamcinolone—Body temperature increased—Doxorubicin—bone cancer	9.91e-05	0.000849	CcSEcCtD
Triamcinolone—Asthenia—Epirubicin—bone cancer	9.73e-05	0.000833	CcSEcCtD
Triamcinolone—Pruritus—Epirubicin—bone cancer	9.59e-05	0.000821	CcSEcCtD
Triamcinolone—Dizziness—Methotrexate—bone cancer	9.58e-05	0.00082	CcSEcCtD
Triamcinolone—Dexamethasone—CYP3A4—bone cancer	9.57e-05	0.0179	CrCbGaD
Triamcinolone—Dexamethasone—PTGS2—bone cancer	9.37e-05	0.0175	CrCbGaD
Triamcinolone—Hypersensitivity—Doxorubicin—bone cancer	9.24e-05	0.000791	CcSEcCtD
Triamcinolone—Vomiting—Methotrexate—bone cancer	9.21e-05	0.000789	CcSEcCtD
Triamcinolone—Rash—Methotrexate—bone cancer	9.13e-05	0.000782	CcSEcCtD
Triamcinolone—Dermatitis—Methotrexate—bone cancer	9.12e-05	0.000781	CcSEcCtD
Triamcinolone—Headache—Methotrexate—bone cancer	9.07e-05	0.000777	CcSEcCtD
Triamcinolone—Asthenia—Doxorubicin—bone cancer	9e-05	0.000771	CcSEcCtD
Triamcinolone—Dizziness—Epirubicin—bone cancer	8.96e-05	0.000768	CcSEcCtD
Triamcinolone—Pruritus—Doxorubicin—bone cancer	8.87e-05	0.00076	CcSEcCtD
Triamcinolone—Vomiting—Epirubicin—bone cancer	8.62e-05	0.000738	CcSEcCtD
Triamcinolone—Nausea—Methotrexate—bone cancer	8.6e-05	0.000737	CcSEcCtD
Triamcinolone—Rash—Epirubicin—bone cancer	8.55e-05	0.000732	CcSEcCtD
Triamcinolone—Dermatitis—Epirubicin—bone cancer	8.54e-05	0.000731	CcSEcCtD
Triamcinolone—Headache—Epirubicin—bone cancer	8.49e-05	0.000727	CcSEcCtD
Triamcinolone—Dizziness—Doxorubicin—bone cancer	8.29e-05	0.00071	CcSEcCtD
Triamcinolone—Nausea—Epirubicin—bone cancer	8.05e-05	0.00069	CcSEcCtD
Triamcinolone—Vomiting—Doxorubicin—bone cancer	7.97e-05	0.000683	CcSEcCtD
Triamcinolone—Rash—Doxorubicin—bone cancer	7.91e-05	0.000677	CcSEcCtD
Triamcinolone—Dermatitis—Doxorubicin—bone cancer	7.9e-05	0.000677	CcSEcCtD
Triamcinolone—Headache—Doxorubicin—bone cancer	7.86e-05	0.000673	CcSEcCtD
Triamcinolone—Nausea—Doxorubicin—bone cancer	7.45e-05	0.000638	CcSEcCtD
